Delivery Order SPE2DB22D2206-SPE2DB24FFZ53

Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a pharmaceutical product. The potential value of this delivery order is $1,951.96, with a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a specialty pharmaceutical product, with a potential value of $1,662.96 and a completion date of March 7, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The $1,037.76 contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, a branded pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 to deliver pharmaceuticals and medical supplies to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distributor. The $2,183.54 order is for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, to be delivered by February 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation (AmerisourceBergen), a for-profit pharmaceutical and medical supply distributor, as the prime contractor. The award has a ceiling value of $1,207.93 and an ultimate completion date of April 2, 2024. It is a firm fixed price contract for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a brand name pharmaceutical product. AmerisourceBergen holds an...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, with a completion date of February 2, 2024 and a potential value of $1,881.39. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp serves as the prime contractor,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceutical products, specifically MICARDIS HCT 80-25 MG TABLET UD 30S, with a ceiling value of $1,517.13 and a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of Micardis HCT 80-12.5 mg tablets, with a potential value of $1,269.08 and a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a branded pharmaceutical product, with a potential value of $1,816.08 and a completion date of February 14, 2024. The contract is a firm fixed price award and does not have a set-aside designation....
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,332.04 and will provide the MICARDIS HCT 80-25 MG TABLET UD 30S pharmaceutical product to the DLA Troop Support Medical facilities in support of military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor and the order does not have...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FFZ53
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, with a potential value of $1,037.76 and a completion date of March 8, 2024.

Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that specializes in providing pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide. No set-aside designation was used for this particular delivery order.

Generated 6/6/24, 10:20 AM